Drag a card by its title · ⚙ to size, swap or remove

The company

Serina Therapeutics, Inc.

SER · NYSE American

Health CareBiotechnologyNot moving yet

SER stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 7 weeks. It is 21.3% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 7
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $156K
Insider sales, 12 months: $676K
Officials’ trades on record: 0
Institutions holding: 27 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months7

Sale orders, 12 months27

Buyers · sellers4 · 1

Who	Did	Shares	Traded
Stephen K. BrannanDirector	bought	1,000at $2.03	7 Jul 2026filed 9 Jul 2026
Karen J. WilsonDirector	bought	5,000at $1.77	12 Jun 2026filed 15 Jun 2026
Karen J. WilsonDirector	bought	5,100at $1.75	11 Jun 2026filed 15 Jun 2026
Karen J. WilsonDirector	bought	10,000at $1.93	22 May 2026filed 26 May 2026
Jay VenkatesanDirector	bought	589at $1.78	22 May 2026filed 22 Jun 2026
Karen J. WilsonDirector	bought	10,000at $1.77	21 May 2026filed 26 May 2026
Richard Peter MarshallDirector	bought	12,183at $1.65	19 May 2026filed 22 May 2026
Randall MoreadithChief Scientific Officer	sold	6,500at $2.86	23 Mar 2026filed 24 Mar 2026
Randall MoreadithChief Scientific Officer	sold	39,000at $2.50	19 Mar 2026filed 20 Mar 2026
Randall MoreadithChief Scientific Officer	sold	6,500at $3.03	2 Feb 2026filed 3 Feb 2026
Randall MoreadithChief Scientific Officer	sold	6,500at $3.57	28 Jan 2026filed 29 Jan 2026
Randall MoreadithChief Scientific Officer	sold	2,500at $2.95	22 Jan 2026filed 23 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders27+2 on the quarter

New · exited5 · 3

Reported value$2.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Sio Capital Management, LLCunchanged · filed 14 Aug 2026	1,000,000$1.9M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	162,198$315K	+3,062+1.9%
Waverly Advisors, LLCunchanged · filed 14 Aug 2026	67,492$131K	00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	51,007$99K	-13,966−21.5%
Keel Point, LLCunchanged · filed 14 Aug 2026	21,508$42K	00.0%
NORTHERN TRUST CORPnew · filed 13 Aug 2026	20,771$40K	+20,771
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	20,009$39K	00.0%
Avidian Wealth Enterprises, LLCunchanged · filed 24 Jul 2026	18,800$36K	00.0%
JANE STREET GROUP, LLCreduced · filed 14 Aug 2026	15,444$30K	-24,209−61.1%
STATE STREET CORPunchanged · filed 7 Aug 2026	12,758$25K	00.0%